Orchestra BioMed Holdings Files Definitive Proxy Statement
Ticker: OBIO · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1814114
| Field | Detail |
|---|---|
| Company | Orchestra Biomed Holdings, Inc. (OBIO) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Orchestra BioMed proxy filed - shareholders vote soon on company direction.
AI Summary
Orchestra BioMed Holdings, Inc. filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 24, 2025. The company, formerly known as Health Sciences Acquisitions Corp 2, is seeking shareholder approval for matters related to its business operations and corporate governance. The filing provides details on executive compensation, director elections, and other proposals requiring shareholder votes.
Why It Matters
This filing is crucial for shareholders as it outlines the proposals they will vote on at the upcoming annual meeting, impacting the company's future direction and governance.
Risk Assessment
Risk Level: medium — Proxy statements often contain proposals that can significantly alter a company's strategic direction, financial structure, or governance, requiring careful shareholder consideration.
Key Players & Entities
- Orchestra BioMed Holdings, Inc. (company) — Registrant
- Health Sciences Acquisitions Corp 2 (company) — Former company name
- April 30, 2025 (date) — Filing date
- June 24, 2025 (date) — Annual meeting date
FAQ
What is the purpose of this DEF 14A filing?
This filing is a definitive proxy statement filed by Orchestra BioMed Holdings, Inc. to provide shareholders with information regarding the matters to be voted on at the company's annual meeting of shareholders.
When is the annual meeting of shareholders scheduled?
The annual meeting of shareholders is scheduled for June 24, 2025.
What was Orchestra BioMed Holdings, Inc. formerly known as?
Orchestra BioMed Holdings, Inc. was formerly known as Health Sciences Acquisitions Corp 2.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 30, 2025.
Where is Orchestra BioMed Holdings, Inc. located?
The company's business and mailing address is 150 Union Square Drive, New Hope, PA 18938.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Orchestra BioMed Holdings, Inc. (OBIO).